Lenalidomide is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Lenalidomide.
| Product ID | 0378-1940_76f6c1e7-985b-43d9-892c-849df50ae80e |
| NDC | 0378-1940 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lenalidomide |
| Generic Name | Lenalidomide |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-09-03 |
| Marketing Category | ANDA / |
| Application Number | ANDA213912 |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | LENALIDOMIDE |
| Active Ingredient Strength | 25 mg/1 |
| Pharm Classes | Thalidomide Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-09-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-1936 | Lenalidomide | Lenalidomide |
| 0378-1937 | Lenalidomide | Lenalidomide |
| 0378-1940 | Lenalidomide | Lenalidomide |
| 0378-1941 | Lenalidomide | Lenalidomide |
| 0480-1242 | Lenalidomide | Lenalidomide |
| 0480-1243 | Lenalidomide | Lenalidomide |
| 0480-1244 | Lenalidomide | Lenalidomide |
| 0480-1246 | Lenalidomide | Lenalidomide |
| 43598-511 | Lenalidomide | Lenalidomide |
| 43598-512 | Lenalidomide | Lenalidomide |
| 43598-513 | Lenalidomide | Lenalidomide |
| 43598-514 | Lenalidomide | Lenalidomide |
| 43598-515 | Lenalidomide | Lenalidomide |
| 43598-516 | Lenalidomide | Lenalidomide |
| 47781-484 | LENALIDOMIDE | Lenalidomide |
| 47781-485 | LENALIDOMIDE | Lenalidomide |
| 47781-486 | LENALIDOMIDE | Lenalidomide |
| 47781-488 | LENALIDOMIDE | Lenalidomide |
| 59572-402 | Revlimid | Lenalidomide |
| 59572-405 | Revlimid | Lenalidomide |